Biotech-in-a-Box, CDD’s Solution for Combating the Opioid Crisis Burlingame, California — Collaborative Drug Discovery, Inc. (CDD) won $120,000 in the 2nd competitive stage of an NCATS ASPIRE Challenge hosted by the National Institutes of Health. In Oct 2019, CDD won $100,000 in the 1st competitive stage. For this challenge CDD designed a unique screening program that NCATS can […]
HexagonFab secures £1.9m (USD 2.6m) seed funding to launch the Bolt, an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals The Bolt provides convenient and affordable access to molecular binding analytics Cambridge/Zurich – University of Cambridge spin-out company HexagonFab today announces a £1.9 million (USD 2.6 million) seed funding round, led by Cambridge […]
SANTA CLARA, Calif. — Park Systems, world leading manufacturer of Atomic Force Microscopes announced the company stock valuation exceeded 1 Trillion KRW (almost $1 Billion USD) at the end of KOSDAQ on April 5, 2021. Park Systems issued 1 million shares for its initial public offering on December 17th, 2015 at KOSDAQ, a NASDAQ equivalent in Korea. Since the IPO, the company has progressed […]
MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the closing of its initial public offering of 7,567,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase 987,000 additional shares of common stock, at the initial public offering price of […]
Backed by global investor syndicate led by new investors Farallon Capital Management and Lauxera Capital Partners along with Softbank Fund 2, funds and accounts advised by T. Rowe Price Associates, Parian Global Management, Gilde Healthcare, Pura Vida Investments, and Irving Investors. Amsterdam, the Netherlands – LUMICKS, a leading, next generation life science tools company that develops […]
SAN DIEGO — Molecular Assemblies, Inc., today announced that it has closed an oversubscribed $24 million Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures. In addition LYFE Capital has joined the syndicate. The proceeds of the financing will be used to advance the company’s proprietary […]
Led by Sequoia, new funding will fuel life sciences cloud leader’s global growth and product expansion SAN FRANCISCO — Benchling, the leading life sciences R&D cloud, has raised $200 million in Series E funding led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital and Elad Gil. Existing investors participated, including Thrive […]
Funding will accelerate company growth and infrastructure expansion leading up to full commercial launch Vizgen, the life science company dedicated to advancing human health by visualizing single-cell spatial genomics information, has closed a $37 million Series B financing. The financing was co-led by Novalis LifeSciences LLC, and current investor Northpond Ventures. Also participating in the round were […]
CDD Awarded $1.5M Phase 2 SBIR Grant on an Intelligent Chemical Structure Browser for Drug Discovery and Optimization Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 2 SBIR grant from NIH NCATS, titled: “Intelligent Chemical Structure Browser for Drug Discovery and Optimization”. This […]
GeneMill at the University of Liverpool receives first benchtop Onyx platform in Europe Financing round led by Fidelity and T. Rowe Price funds underscores vast opportunities to bring Inscripta’s CRISPR-based technology to the broader bioeconomy Inscripta, Inc., the digital genome engineering company, today announced the first commercial shipment of its Onyx™ platform and the closing of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
